Literature DB >> 15502930

High amniotic fluid erythropoietin levels are associated with an increased frequency of fetal and neonatal morbidity in type 1 diabetic pregnancies.

K Teramo1, M A Kari, M Eronen, H Markkanen, V Hiilesmaa.   

Abstract

AIMS/HYPOTHESIS: In this study we investigated whether chronic fetal hypoxia, as indicated by amniotic fluid erythropoietin levels, is associated with perinatal morbidity in type 1 diabetic pregnancies.
METHODS: A total of 331 women with type 1 diabetes had at least one childbirth between 1995 and 2000. The amniotic fluid erythropoietin concentration was measured in 156 diabetic singleton pregnancies at a median time of 1 day before Caesarean section without labour contractions and in 19 healthy control subjects at Caesarean section.
RESULTS: The median amniotic fluid erythropoietin level was 14.0 mU/ml (range 2.0-1975.0) in diabetic pregnancies and 6.3 mU/ml (range 1.7-13.7) in controls (p<0.0001). Of the 156 diabetic patients, 21 (13.5%) had amniotic fluid erythropoietin levels higher than 63.0 mU/ml. Amniotic fluid erythropoietin levels correlated negatively with umbilical artery pH (r=-0.49, p<0.0001) and pO2 (r=-0.62, p<0.0001) at birth and neonatal lowest blood glucose level (r=-0.47, p<0.0001). Positive correlations were found between amniotic fluid erythropoietin levels and umbilical artery pCO2 (r=0.49, p<0.0001) and last maternal HbA1c (r=0.43, p<0.0001). Furthermore, a U-shaped correlation was demonstrated between amniotic fluid erythropoietin levels and birthweight z score (z score below -0.6 SD units: r=-0.63, p=0.0007; z score above +1.0 SD units: r=0.32, p=0.0014). Neonatal hypoglycaemia, hypertrophic cardiomyopathy and admission to the neonatal intensive care unit occurred significantly more often in cases with high amniotic fluid erythropoietin levels (>63.0 mU/ml) than in those with normal levels. Multivariate logistic regression analysis revealed that amniotic fluid erythropoietin was the only variable independently related to low umbilical artery pH (<7.21; p<0.0001) and neonatal hypoglycaemia (p=0.002). Low umbilical artery pO2 (<15.0 mm Hg) was explained by amniotic fluid erythropoietin (p<0.0001) and birthweight z score (p=0.004). CONCLUSIONS/
INTERPRETATION: Antenatal high amniotic fluid erythropoietin levels can identify type 1 diabetic pregnancies at increased risk of severe perinatal complications.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15502930     DOI: 10.1007/s00125-004-1515-3

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  30 in total

1.  Pregnancy and diabetes mellitus; a clinical study.

Authors:  L HAGBARD
Journal:  Acta Obstet Gynecol Scand Suppl       Date:  1956

2.  Direct relationship of antepartum glucose control and fetal erythropoietin in human type 1 (insulin-dependent) diabetic pregnancy.

Authors:  J A Widness; K A Teramo; G K Clemons; P Voutilainen; U H Stenman; S M McKinlay; R Schwartz
Journal:  Diabetologia       Date:  1990-06       Impact factor: 10.122

3.  Supply of oxygen to the fetus.

Authors:  G Meschia
Journal:  J Reprod Med       Date:  1979-10       Impact factor: 0.142

4.  Erythropoietin elevation in the chronically hyperglycemic fetal lamb.

Authors:  A F Philipps; J A Widness; J F Garcia; J R Raye; R Schwartz
Journal:  Proc Soc Exp Biol Med       Date:  1982-05

5.  Increased erythropoiesis and elevated erythropoietin in infants born to diabetic mothers and in hyperinsulinemic rhesus fetuses.

Authors:  J A Widness; J B Susa; J F Garcia; D B Singer; P Sehgal; W Oh; R Schwartz; H C Schwartz
Journal:  J Clin Invest       Date:  1981-03       Impact factor: 14.808

6.  Erythropoietin prevents neuronal apoptosis after cerebral ischemia and metabolic stress.

Authors:  A L Sirén; M Fratelli; M Brines; C Goemans; S Casagrande; P Lewczuk; S Keenan; C Gleiter; C Pasquali; A Capobianco; T Mennini; R Heumann; A Cerami; H Ehrenreich; P Ghezzi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-20       Impact factor: 11.205

7.  Antepartum surveillance in diabetic pregnancies: predictors of fetal distress in labor.

Authors:  S L Kjos; A Leung; O A Henry; M R Victor; R H Paul; A L Medearis
Journal:  Am J Obstet Gynecol       Date:  1995-11       Impact factor: 8.661

8.  Amniotic fluid and cord plasma erythropoietin levels in pregnancies complicated by preeclampsia, pregnancy-induced hypertension and chronic hypertension.

Authors:  Kari A Teramo; Vilho K Hiilesmaa; Robert Schwartz; Gisela K Clemons; John A Widness
Journal:  J Perinat Med       Date:  2004       Impact factor: 1.901

9.  Fetal plasma erythropoietin in pregnancies complicated by maternal diabetes mellitus.

Authors:  D R Salvesen; J M Brudenell; R J Snijders; R M Ireland; K H Nicolaides
Journal:  Am J Obstet Gynecol       Date:  1993-01       Impact factor: 8.661

10.  Amniotic fluid erythropoietin correlates with umbilical plasma erythropoietin in normal and abnormal pregnancy.

Authors:  K A Teramo; J A Widness; G K Clemons; P Voutilainen; S McKinlay; R Schwartz
Journal:  Obstet Gynecol       Date:  1987-05       Impact factor: 7.661

View more
  26 in total

1.  Obstetric and perinatal outcome in type 1 diabetes patients with diabetic nephropathy during 1988-2011.

Authors:  Miira M Klemetti; Hannele Laivuori; Minna Tikkanen; Mika Nuutila; Vilho Hiilesmaa; Kari Teramo
Journal:  Diabetologia       Date:  2015-01-10       Impact factor: 10.122

Review 2.  Erythropoietin and diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  World J Diabetes       Date:  2015-10-25

Review 3.  Novel avenues of drug discovery and biomarkers for diabetes mellitus.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

Review 4.  Triple play: promoting neurovascular longevity with nicotinamide, WNT, and erythropoietin in diabetes mellitus.

Authors:  Kenneth Maiese
Journal:  Biomed Pharmacother       Date:  2008-02-20       Impact factor: 6.529

Review 5.  Raves and risks for erythropoietin.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang
Journal:  Cytokine Growth Factor Rev       Date:  2008-03-04       Impact factor: 7.638

Review 6.  Erythropoietin and oxidative stress.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Curr Neurovasc Res       Date:  2008-05       Impact factor: 1.990

Review 7.  Oxidative stress: Biomarkers and novel therapeutic pathways.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Exp Gerontol       Date:  2010-01-11       Impact factor: 4.032

8.  Obstetric and perinatal outcomes in type 1 diabetic pregnancies: A large, population-based study.

Authors:  Martina Persson; Mikael Norman; Ulf Hanson
Journal:  Diabetes Care       Date:  2009-08-12       Impact factor: 19.112

Review 9.  Erythropoietin, forkhead proteins, and oxidative injury: biomarkers and biology.

Authors:  Kenneth Maiese; Jinling Hou; Zhao Zhong Chong; Yan Chen Shang
Journal:  ScientificWorldJournal       Date:  2009-10-02

Review 10.  Increased fetal plasma and amniotic fluid erythropoietin concentrations: markers of intrauterine hypoxia.

Authors:  Kari A Teramo; John A Widness
Journal:  Neonatology       Date:  2008-09-06       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.